Literature DB >> 29045354

The Case for Thoughtful Prescribing of Proton Pump Inhibitors in Infants.

Rachel L Rosen1, Usha Krishnan2, Hayat Mousa3, Luigi Dall'oglio4, Christophe Faure5, Frederic Gottrand6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29045354      PMCID： PMC5765768          DOI： 10.1097/MPG.0000000000001794

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  5 in total

1.  National Study of Off-label Proton Pump Inhibitor Use Among New Zealand Infants in the First Year of Life (2005-2012).

Authors:  Mei-Ling Blank; Lianne Parkin
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-08       Impact factor: 2.839

2.  Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux.

Authors:  David John Moore; Billy Siang-Kuo Tao; David Robin Lines; Craig Hirte; Margaret Lila Heddle; Geoffrey Paul Davidson
Journal:  J Pediatr       Date:  2003-08       Impact factor: 4.406

3.  ESPGHAN-NASPGHAN Guidelines for the Evaluation and Treatment of Gastrointestinal and Nutritional Complications in Children With Esophageal Atresia-Tracheoesophageal Fistula.

Authors:  Usha Krishnan; Hayat Mousa; Luigi Dall'Oglio; Nusrat Homaira; Rachel Rosen; Christophe Faure; Frédéric Gottrand
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-11       Impact factor: 2.839

4.  Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.

Authors:  Susan R Orenstein; Eric Hassall; Wanda Furmaga-Jablonska; Stuart Atkinson; Marsha Raanan
Journal:  J Pediatr       Date:  2008-12-03       Impact factor: 4.406

5.  Neonatal Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Treatment at United States Children's Hospitals.

Authors:  Jonathan L Slaughter; Michael R Stenger; Patricia B Reagan; Sudarshan R Jadcherla
Journal:  J Pediatr       Date:  2016-04-27       Impact factor: 4.406
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.